Adrian Chabowski Selected Research

Adrian Chabowski Research Topics

Disease

52	Insulin Resistance 09/2022 - 07/2006
29	Obesity 09/2022 - 07/2004
15	Inflammation (Inflammations) 05/2022 - 01/2016
15	Non-alcoholic Fatty Liver Disease 03/2022 - 11/2012
12	Type 2 Diabetes Mellitus (MODY) 03/2022 - 09/2006
7	Neoplasms (Cancer) 01/2022 - 07/2008
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2022 - 03/2017
6	Fatty Liver 01/2022 - 01/2014
6	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2021 - 03/2017
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2020 - 01/2014
5	Hypertension (High Blood Pressure) 04/2020 - 05/2016
4	Hyperglycemia 01/2022 - 07/2007
4	Liver Diseases (Liver Disease) 04/2021 - 01/2017
3	Body Weight (Weight, Body) 05/2022 - 01/2015
3	Morbid Obesity 01/2022 - 01/2018
3	Necrosis 09/2021 - 01/2016
3	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 01/2019
3	Leiomyoma (Uterine Fibroids) 01/2016 - 01/2012
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2022 - 03/2022
2	Neuroinflammatory Diseases 01/2022 - 06/2020
2	Metabolic Diseases (Metabolic Disease) 01/2022 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2021 - 10/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2019
2	Overweight 12/2019 - 06/2007
2	Heart Failure 12/2018 - 02/2008
2	Carcinogenesis 10/2017 - 01/2012
2	Fibrosis (Cirrhosis) 01/2017 - 06/2014
2	Myocardial Infarction 05/2016 - 11/2011
2	Glucose Intolerance 04/2016 - 10/2015
2	Hyperlipidemias (Hyperlipidemia) 01/2015 - 01/2014
2	Hyperinsulinism (Hyperinsulinemia) 04/2011 - 07/2007
1	Atrial Fibrillation 09/2022
1	Diabetes Mellitus 09/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2022

Drug/Important Bio-Agent (IBA)

57	LipidsIBA 09/2022 - 06/2006
32	CeramidesIBA 09/2022 - 06/2007
32	Fatty Acids (Saturated Fatty Acids)IBA 09/2022 - 07/2004
28	SphingolipidsIBA 09/2022 - 11/2012
24	Insulin (Novolin)FDA Link 05/2022 - 06/2007
18	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 06/2007
14	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2012
12	DiglyceridesIBA 04/2020 - 07/2007
11	Triglycerides (Triacylglycerol)IBA 01/2022 - 07/2004
10	Biomarkers (Surrogate Marker)IBA 03/2022 - 03/2017
8	AntioxidantsIBA 05/2022 - 01/2018
7	EndocannabinoidsIBA 03/2022 - 05/2016
7	PalmitatesIBA 08/2017 - 06/2006
6	thermozymocidin (myriocin)IBA 03/2017 - 01/2013
5	CannabidiolIBA 05/2022 - 01/2020
5	Streptozocin (Streptozotocin)FDA Link 10/2017 - 01/2014
4	Thioctic Acid (Lipoic Acid)IBA 05/2022 - 09/2021
4	EnzymesIBA 01/2022 - 10/2015
4	Fatty Acid-Binding ProteinsIBA 05/2021 - 01/2016
3	Carrier Proteins (Binding Protein)IBA 09/2022 - 01/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 06/2014
3	CytokinesIBA 01/2022 - 04/2009
3	Interleukin-6 (Interleukin 6)IBA 09/2021 - 03/2018
3	Palmitic Acid (Hexadecanoic Acid)IBA 06/2021 - 01/2019
3	safingol (sphinganine)IBA 06/2021 - 03/2013
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2021 - 01/2019
3	SphingosineIBA 01/2021 - 01/2013
3	SphingomyelinsIBA 08/2019 - 01/2015
3	AdipokinesIBA 04/2019 - 09/2017
3	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 03/2019 - 01/2017
3	ResveratrolIBA 01/2019 - 06/2014
3	LeptinIBA 01/2019 - 11/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018 - 01/2012
3	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2015
3	Coenzyme A (CoA)IBA 01/2016 - 06/2014
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2022 - 01/2014
2	Biological ProductsIBA 05/2022 - 03/2022
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2022 - 09/2018
2	CholesterolIBA 01/2022 - 02/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 06/2020
2	CannabinoidsIBA 01/2021 - 01/2018
2	Phosphates (Orthophosphate)IBA 01/2021 - 03/2013
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2020 - 01/2018
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2019 - 04/2016
2	PolyphenolsIBA 01/2019 - 01/2017
2	AdiponectinIBA 01/2019 - 02/2009
2	Fatty Acid Binding Protein 3IBA 01/2016 - 11/2011
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2016 - 01/2015
2	O(2)- vinyl- 1- (pyrrolidin- 1- yl)diazen- 1- ium- 1,2- diolateIBA 07/2015 - 02/2015
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2015 - 03/2013
2	Metformin (Glucophage)FDA LinkGeneric 02/2015 - 07/2007
1	Matrix Metalloproteinases (MMPs)IBA 04/2022
1	GlobosidesIBA 01/2022
1	GangliosidesIBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022

Therapy/Procedure

4	Therapeutics 02/2022 - 01/2017
2	Injections 04/2020 - 01/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 09/2022
1	Cryosurgery 09/2022
1	Intraperitoneal Injections 02/2022
1	Transplantation 01/2022